Showing results (451-460 of 518) with videos related to
Sort By:
Pageof 52
Oncotarget|July 1, 2015
In1-ghrelin, a splice variant of ghrelin gene, is associated with the evolution and aggressiveness of human neuroendocrine tumors: Evidence from clinical, cellular and molecular parametersRaul M Luque, Miguel Sampedro-Nuñez, Manuel D Gahete, et al.Leukemia Research|February 8, 2022
Diagnostic and prognostic implications of tumor expression of the GATA-3 gene in nodal peripheral T-cell lymphoma (nPTCL): Retrospective data from a Latin American cohortLuís Alberto de Pádua Covas Lage, Cláudio Vinícius Brito, Débora Levy, et al.Biochemical Pharmacology|March 7, 2001
Inhibition of human pancreatic islet insulin release by receptor-selective somatostatin analogs directed to somatostatin receptor subtype 5Y Zambre, Z Ling, M C Chen, et al.Clinical Endocrinology|August 19, 2011
Balance between somatostatin and D2 receptor expression drives TSH-secreting adenoma response to somatostatin analogues and dopastatinsFederico Gatto, Federica Barbieri, Monica Gatti, et al.Journal of Graduate Medical Education|April 26, 2021
Simulation-Based Assessments and Graduating Neurology Residents' Milestones: Status Epilepticus MilestonesYara Mikhaeil-Demo, Eric Holmboe, Elizabeth E Gerard, et al.Endocrinology|March 10, 2007
Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexiaMark D DeBoer, Xin Xia Zhu, Peter Levasseur, et al.Physiology & Behavior|May 11, 2011
Ghrelin, peptide YY and their hypothalamic targets differentially regulate spontaneous physical activityPaul T Pfluger, Tamara R Castañeda, Kristy M Heppner, et al.Cancer Biomarkers : Section a of Disease Markers|September 12, 2022
TET-2 mutations predict poor outcomes and are associated with unfavorable clinical-biological features in PTCL, not otherwise specified and angioimmunoblastic T-cell lymphoma in Brazilian patientsLuís Alberto de Pádua Covas Lage, Guilherme Carneiro Barreto, Hebert Fabricio Culler, et al.JMIR Public Health and Surveillance|April 5, 2021
Surveillance of the Second Wave of COVID-19 in Europe: Longitudinal Trend AnalysesLori Post, Kasen Culler, Charles B Moss, et al.Clinical Lymphoma, Myeloma & Leukemia|July 22, 2022
Up-front Therapy With CHOP Plus Etoposide in Brazilian nodal PTCL Patients: Increased Toxicity and No Survival Benefit Compared to CHOP Regimen-Results of a Real-Life Study From a Middle-Income CountryLuís Alberto de Pádua Covas Lage, Cláudio Vinícius Brito, Guilherme Carneiro Barreto, et al.Pageof 52